Evidence map›Paper›PMID 27888636›Full record

ArticleOncotarget2017

Factors that influence treatment delay in patients with colorectal cancer.

Irene Zarcos-Pedrinaci, Alberto Fernández-López, Teresa Téllez, Francisco Rivas-Ruiz, Antonio Rueda, María Manuela Morales Suarez-Varela, Eduardo Briones, Marisa Baré, Antonio Escobar, Cristina Sarasqueta and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Biomarker Identification through Proteomics in Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  6. Clusterin Expression in Colorectal Carcinomas.International journal of molecular sciences · 2023
    Review
  7. Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer.International journal of environmental research and public health · 2022
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Irene Zarcos-PedrinaciResearch Unit, Agencia Sanitaria Costa del Sol, Marbella, Spain.
Alberto Fernández-LópezServicio de Cirugía, Agencia Sanitaria Costa del Sol, Marbella, Spain.
Teresa TéllezResearch Unit, Agencia Sanitaria Costa del Sol, Marbella, Spain.
Francisco Rivas-RuizResearch Unit, Agencia Sanitaria Costa del Sol, Marbella, Spain.
Antonio RuedaServicio de Oncología Médica, Agencia Sanitaria Costa del Sol, Marbella, Spain.
María Manuela Morales Suarez-VarelaUnit of Public Health, Hygiene and Environmental Health, Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine, University of Valencia, CIBER-Epidemiology and Public Health (CIBERESP), Valencia, Spain.
Eduardo BrionesPublic Health Unit, Distrito Sanitario Sevilla, Consorcio de Investigación Biomédica de Epidemiología y Salud Pública, Madrid, Spain.
Marisa BaréClinical Epidemiology and Cancer Screening, Corporació Sanitària Parc Taulí, Sabadell, Spain.
Antonio EscobarResearch Unit, Hospital Universitario Basurto, Bilbao, Spain.
Cristina SarasquetaResearch Unit, Donostia University Hospital, San Sebastián, Spain.
Nerea Fernández de LarreaArea of Environmental Epidemiology and Cancer, National Epidemiology Centre, Instituto de Salud Carlos III, Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain.
Urko AguirreResearch Unit, Hospital Galdakao-Usansolo, Galdakao, Spain.
José María QuintanaResearch Unit, Hospital Galdakao-Usansolo, Galdakao, Spain.
Maximino RedondoResearch Unit, Agencia Sanitaria Costa del Sol, Marbella, Spain.
CARESS-CCR Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A prospective study was performed of patients diagnosed with colorectal cancer (CRC), distinguishing between colonic and rectal location, to determine the factors that may provoke a delay in the first treatment (DFT) provided.2749 patients diagnosed with CRC were studied. The study population was recruited between June 2010 and December 2012. DFT is defined as time elapsed between diagnosis and first treatment exceeding 30 days.Excessive treatment delay was recorded in 65.5% of the cases, and was more prevalent among rectal cancer patients. Independent predictor variables of DFT in colon cancer patients were a low level of education, small tumour, ex-smoker, asymptomatic at diagnosis and following the application of screening. Among rectal cancer patients, the corresponding factors were primary school education and being asymptomatic.We conclude that treatment delay in CRC patients is affected not only by clinicopathological factors, but also by sociocultural ones. Greater attention should be paid by the healthcare provider to social groups with less formal education, in order to optimise treatment attention.

Indexed as

Time-to-TreatmentAgedBiomarkers, TumorColorectal NeoplasmsDelayed DiagnosisFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedNeoplasm GradingNeoplasm MetastasisNeoplasm StagingOdds RatioRisk FactorsSocioeconomic FactorsBiomarkers, Tumorcancercolorectaldelayeducationtreatment

Identifiers

PMID27888636
PMCPMC5482692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.